BlackRock Fund Advisors recently announced the acquisition of new stake in Apollo Medical Holdings Inc. (NASDAQ:AMEH). The institutional investor has increased its shareholding in the Healthcare company by 3.61% to 5.7 million shares with purchase of 0.2 million shares. This fresh investment now brings its stake to 10.05% valued currently at $168.7 million. In addition, The Vanguard Group, Inc. raised its holdings by 65785.0 to 4.17 million shares. And SSgA Funds Management, Inc. has lifted its position by 2.76% or 35188.0 shares – to 1.31 million shares.
With over 0.25 million Apollo Medical Holdings Inc. (AMEH) shares trading Friday and a closing price of $35.90 on the day, the dollar volume was approximately $8.91 million. The shares have shown a negative half year performance of -22.85% and its price on 01/13/23 gained nearly 1.87%. Currently, there are 44.95M common shares owned by the public and among those 39.43M shares have been available to trade.
The analysts have set the share’s price value over the next 12 months at a high of $40.00 and a low of $40.00. The average price target is 7.95% above its recent price level and an upside to the estimated low will see the stock gain 10.25% over that period. But an upside of 10.25% will see the stock hit the forecast high price target while median target price for the stock is $40.00.
Insiders at the company have transacted a total of 20 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 13 of these insider trades were purchases, accounting for 1,351,907 shares. Insider sales of the common stock occurred on 7 occasions, with total insider shares sold totaling 4,189,439 shares.
The top 3 mutual fund holders in Apollo Medical Holdings Inc. are iShares Core S&P Small Cap ETF, Vanguard Total Stock Market Index, and Vanguard Small Cap Index Fund. iShares Core S&P Small Cap ETF owns 2.93 million shares of the company’s stock, all valued at over $86.57 million. The company sold 2224.0 shares recently to bring their total holdings to about 5.16% of the shares outstanding. Vanguard Total Stock Market Index bought 1801.0 shares to see its total holdings expand to 1.19 million shares valued at over $35.22 million and representing 2.10% of the shares outstanding. Vanguard Small Cap Index Fund bought 84.0 shares to bring its total holdings to over 1.02 million shares at a value of $30.21 million. Vanguard Small Cap Index Fund now owns shares totaling to 1.80% of the shares outstanding.
Shares of Apollo Medical Holdings Inc. (NASDAQ: AMEH) opened at $34.83, down -$0.41 from a prior closing price of $35.24. However, the script later moved the day high at 36.00, up 1.87%. The company’s stock has a 5-day price change of 26.63% and 7.74% over the past three months. AMEH shares are trading 21.32% year to date (YTD), with the 12-month market performance down to -44.15% lower. It has a 12-month low price of $26.89 and touched a high of $65.89 over the same period. AMEH has an average intraday trading volume of 287.14K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 20.08%, 16.50%, and -6.81% respectively.
Institutional ownership of Apollo Medical Holdings Inc. (NASDAQ: AMEH) shares accounts for 36.00% of the company’s 44.95M shares outstanding. Mutual fund holders own 23.76%, while other institutional holders and individual stakeholders account for 27.32% and 11.51% respectively.
It has a market capitalization of $2.00B and a beta (3y monthly) value of 0.71. The stock’s trailing 12-month PE ratio is 25.23, while the earnings-per-share (ttm) stands at $1.42. The company has a PEG of 2.36 and a Quick Ratio of 2.80 with the debt-to-equity ratio at 0.40. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.68% over the week and 6.02% over the month.
Analysts forecast that Apollo Medical Holdings Inc. (AMEH) will achieve an EPS of $0.32 for the current quarter, $0.34 for the next quarter and $1.54 for 2023. The lowest estimate earnings-per-share for the quarter is $0.2 while analysts give the company a high EPS estimate of $0.44. Comparatively, EPS for the current quarter was $0.74 a year ago. Earnings per share for the fiscal year are expected to increase by 60.90%, and -5.37% over the next financial year. EPS should shrink at an annualized rate of 10.70% over the next five years, compared to 25.30% over the past 5-year period.
Looking at the support for the AMEH, a number of firms have released research notes about the stock. Lake Street stated their Buy rating for the stock in a research note on December 19, 2022, with the firm’s price target at $40. Colliers Securities was of a view on January 11, 2022 that the stock is Buy, while Barclays gave the stock Equal Weight rating on August 12, 2021, issuing a price target of $92.